Purchase any WEBINAR and get
10% Off
CODE: SAVE10
T&C applicable, please referFAQ
Validity : 18th Apr'24 to 28th Apr'24
The Healthcare Disruptors: Impact Amazon & Other Big Tech Companies Are Having On Healthcare Industry
- Evaluate key factors driving healthcare disruption
- Anticipated market impact from the CVS Aetna merger
- Overview of other Amazon initiatives to disrupt healthcare
- Outlook for future big tech disruption of healthcare industry
- Find out why big technological companies are entering the healthcare industry
- Discover why the new CVS-Aetna venture stands out from other vertical healthcare mergers
- Leading characteristics of big tech companies which are propelling their involvement in healthcare
- Assess why an increasing number of non-traditional partners will be linking up with key healthcare players
- Explain why the health insurance industry is ripe for disruption and what tech companies are doing to enter this sector
- Discuss the Amazon venture with JP Morgan-Chase and Berkshire-Hathaway and determine why it may be able to finally crack the healthcare cost code
Overview of the webinar
- Characterized by prohibitive spending, inefficiency, burdensome regulation and increasing frustration among virtually all industry stakeholders, America’s healthcare system has finally reached a tipping point
- The market forces that have disrupted other service industries—from travel to retail to mobile phones—have so far made only tentative inroads into healthcare
- Utilizing their competitive advantages in data analytics, artificial intelligence software and consumer relationships among others, big tech companies are now creating some innovative healthcare products
- Amazon is the most high-profile would-be disruptor in the news given its joint venture with Berkshire Hathaway and JP Morgan Chase to develop an innovative way to approach health insurance aimed at reducing health care costs and improving outcomes and initially focusing on the combined group’s one or so million employees
- Apple also released an iPhone offering users in several big health systems instant access to their own medical record. This effort joins Apple’s ongoing heart study with Stanford, testing whether wearables can detect serious heart conditions. Google’s parent company, Alphabet which has formed two subsidiaries to specifically focus on healthcare — Calico and Verity Life Sciences
- While the former is increasingly focusing on the human life span, Verity’s efforts are in developing new technology to treat diseases and manage population health. Meantime, some key healthcare players have started to seek out nontraditional partners to confront spiraling healthcare costs. Most recently grabbing the spotlight is the combining of CVS Health and Aetna to offer more cost-effective and convenient access to care and services
Who should attend?
- Chief Operating Officer
- Chief Financial Officer
- Chief Technology Officer
- Chief Data Officer
- Chief Information Officer
- Chief Compliance Officer
- Chief Knowledge Officer
- Chief Medical Officer
- Chief Marketing Officer
- Vice President
- Senior managers
- Director
- Sales
- Finance
- Distribution
- Planning
- Business Development
Why should you attend?
- With annual spending in healthcare now at $3.5 trillion, the healthcare industry comprises 21% of the U.S. economy
- Despite investing far more in healthcare than any other country, the American healthcare system produces mediocre results at best in terms of affordability, quality, access, and outcome
- Disruption is now coming from both inside a healthcare industry even as past efforts have fallen short when it comes to lowering costs
- As Amazon and other big tech companies start moving into healthcare, their success will ultimately be measured by their ability to have a meaningful impact on healthcare pricing
- Among other critical issues which need to be addressed by the big tech disruptors: can they ameliorate what many see as the biggest underlying challenges for healthcare: lifestyle behaviors and socio- economic conditions and, will they promote or distract from a market-driven healthcare model
Faculty - Mr.Dennis Weissman
Dennis Weissman, A nationally recognized, independent analyst and thought leader in the diagnostic field for over three decades, Dennis is President of Dennis Weissman & Associates, LLC, Falls Church, VA, a consultancy which provides market intelligence, M&A advisory services, business leadership and public policy advice to diagnostic and life science companies and organizations. He has expertise in Medicare and health care reform policies and trends; clinical lab and pathology payment & compliance policies as well as business trends affecting the diagnostic sector. Dennis founded and served as publisher of Washington G-2 Reports (now G2 Intelligence) through 1999, an information company that reports on and analyzes the U.S. clinical laboratory industry via newsletters, research reports and conferences. Prior to G2, he served as the Director of the Washington Office of the American Society for Medical Technology (now ASCLS) and before that, Special Assistant to the Deputy Assistant Secretary for Health, Department of Health, Education & Welfare (now HHS).